Two distinct mechanisms of RNA polymerase II elongation stimulation in vivo

Mol Cell. 2021 Aug 5;81(15):3096-3109.e8. doi: 10.1016/j.molcel.2021.05.028. Epub 2021 Jun 18.

Abstract

Transcription by RNA polymerase II (RNA Pol II) relies on the elongation factors PAF1 complex (PAF), RTF1, and SPT6. Here, we use rapid factor depletion and multi-omics analysis to investigate how these elongation factors influence RNA Pol II elongation activity in human cells. Whereas depletion of PAF subunits PAF1 and CTR9 has little effect on cellular RNA synthesis, depletion of RTF1 or SPT6 strongly compromises RNA Pol II activity, albeit in fundamentally different ways. RTF1 depletion decreases RNA Pol II velocity, whereas SPT6 depletion impairs RNA Pol II progression through nucleosomes. These results show that distinct elongation factors stimulate either RNA Pol II velocity or RNA Pol II progression through chromatin in vivo. Further analysis provides evidence for two distinct barriers to early elongation: the promoter-proximal pause site and the +1 nucleosome. It emerges that the first barrier enables loading of elongation factors that are required to overcome the second and subsequent barriers to transcription.

Keywords: CTR9; PAF1; RNA polymerase II; RTF1; SPT6; dTAG; dTAG7; transcription; transcription elongation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • K562 Cells
  • Nucleosomes / genetics
  • Nucleosomes / metabolism
  • Phosphoproteins / genetics
  • Phosphoproteins / metabolism
  • RNA / biosynthesis*
  • RNA Polymerase II / genetics
  • RNA Polymerase II / metabolism*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*

Substances

  • CTR9 protein, human
  • Nucleosomes
  • PAF1 protein, human
  • Phosphoproteins
  • RTF1 protein, human
  • SUPT6H protein, human
  • Transcription Factors
  • RNA
  • RNA Polymerase II